Multi-Stakeholder Approach Helped Push SPC Waiver Up The EU Agenda, Says Medicines For Europe

Medicines for Europe, the association that represents companies marketing generics, biosimilars and 'value-added' medicines, has called on its members to press the European Commission to introduce a manufacturing waiver for drugs still protected by a supplementary protection certificate (SPC) 'as soon as possible.'